◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Shionogi & Co., Ltd. (4507) Financial History

Name: Shionogi & Co., Ltd. (4507) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

Shionogi & Co., Ltd. (4507) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Kita, Japan with about 6,223 employees. Its market capitalization is roughly JPY 2.42 trillion. In the fiscal year ended 2026-03-31, 4507 reported JPY 499.7B in revenue and JPY 205.2B in net income.

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

Interactive charts & full statements →

4507 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	JPY 499.7B	JPY 438.3B	JPY 435.1B	JPY 426.7B	—
Gross Profit	JPY 417.2B	JPY 374.4B	JPY 377.5B	JPY 364.4B	—
Operating Income (EBIT)	JPY 166.7B	JPY 156.6B	JPY 153.3B	JPY 149.0B	—
Net Income	JPY 205.2B	JPY 170.4B	JPY 162.0B	JPY 185.0B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4507 Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(JPY 56.2B)	(JPY 48.7B)	(JPY 43.9B)	(JPY 36.1B)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4507 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	JPY 2.58T	JPY 1.54T	JPY 1.42T	JPY 1.31T	—
Total Liabilities	JPY 890.7B	JPY 172.9B	JPY 164.4B	JPY 189.9B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4507 viewer.

4507 Metric Deep Dives

Other Companies in Drug Manufacturers - Specialty & Generic

4502 · Takeda Pharmaceutical Company Limited — $8.91 trillion
4523 · Eisai Co., Ltd. — $1.40 trillion
4151 · Kyowa Kirin Co., Ltd. — $1.34 trillion
4506 · Sumitomo Pharma Co., Ltd. — $603 billion
1276 · Jiangsu Hengrui Pharmaceuticals Co.,Ltd — $382 billion
4540 · Tsumura & Co. — $280 billion
4516 · Nippon Shinyaku Co., Ltd. — $242 billion
3692 · Hansoh Pharmaceutical Group Company Limited — $200 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← 4506 All “0-9” companies 4512 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.